K-Ras, which targets the plasma membrane through electrostatic interactions with phosphatidylserine, undergoes nanoclustering and amplifies MAPK signaling in fibroblasts, neuroblastoma cells, and Drosophila neurons (Zhou et al., 2015). The gene discussed is KRAS; the disease is neuroblastoma.